Kenvue

Kenvue Forward P/E

The Forward P/E Ratio of Kenvue (KVUE) as of Oct 30, 2026 is 24.37. In the previous year, Forward P/E Ratio was 34.79 — a change of -29.93% (lower).

Forward P/E

24.37

YoY

-29.93%

Last updated:

Forward P/E Ratio of Kenvue is 2025 24.37 . Forward P/E Ratio of Kenvue was 2024 34.79 . It decreases by -29.93% lower compared to the previous year.

The Kenvue Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2019
24.97 USD
Jan 1, 2020
-40.76 USD
Jan 1, 2021
17.24 USD
Jan 1, 2022
17.36 USD
Jan 1, 2023
21.53 USD
Jan 1, 2024
34.79 USD
Jan 1, 2025
24.37 USD
The Kenvue Forward P/E history
YEARForward P/EYoY
24.37-29.93%
34.79+61.55%
21.53+24.04%
17.36+0.68%
17.24-142.30%
-40.76-263.25%
24.97—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Kenvue Stock analysis

What does Kenvue do? Kenvue Inc. generates revenue through its three business segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment sells products like Tylenol for pain care, Zyrtec for allergies, and Nicorette for smoking cessation. The Skin Health and Beauty segment offers Neutrogena face and body care, Listerine for oral hygiene, and Aveeno for skin health. Essential Health includes Johnson’s baby care, Band-Aid for wound care, and oral care products. These brands target consumers globally across 165 countries, with distribution via 114 centers and 38 customer service hubs. Kenvue’s differentiated brand portfolio drives sales, with Tylenol, Neutrogena, and Listerine as key products. The Self Care segment focuses on cough, cold, and allergy remedies, while Skin Health and Beauty emphasizes face and body care. Essential Health covers oral care, baby care, and women’s health products. The company serves consumers directly through retail channels in all regions, leveraging its global distribution network. The company’s revenue streams come from selling its branded products in self-care, skin health, and essential health categories. Tylenol leads in pain care, Neutrogena dominates face and body care, and Johnson’s is prominent in baby care. Brands like Listerine and Aveeno cater to oral and skin health needs, while Band-Aid addresses wound care. Sales occur across 165 countries through 114 distribution centers and 38 customer service centers. Kenvue is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kenvue stock

Forward P/E Ratio of Kenvue is 24.37 in 2025.

Forward P/E Ratio of Kenvue changed from 34.79 to 24.37, representing a -29.93% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Kenvue since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Kenvue with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Kenvue

All Key Metrics — Kenvue